Publication | Closed Access
Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosis
40
Citations
23
References
2020
Year
Disease PsychosisPsychoactive DrugPsychiatryMedicineLong-term EvaluationPsychotropic MedicationPsychopharmacologyNeuropharmacologyPharmacotherapyNeurologyBiological PsychiatryOpen-label Pimavanserin SafetyDopaminePharmacology
| Year | Citations | |
|---|---|---|
Page 1
Page 1